 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
HOME / OUR MISSION / HEART FAILURE & TRANSPLANT PROGRAM
Maintaining Excellence in Heart Failure Research and Care Our highly skilled specialists command universal recognition and acclaim for their contributions through research studies, publications, and teaching. Very often, specialists from other health care and academic health centers across Ontario and Canada, will refer their sickest patients to the Heart Function Program at the PMCC as a last resort, when they have exhausted all of their surgical and medical options. Our specialists have used this trend as an opportunity to engage in research and develop diagnostic and treatment savvy expertise that is unparalleled across the province and country. Such international attention has made the PMCC a highly visible target for the attempted recruitment of heart specialists to peripheral” centres in the Greater Toronto Area as well as to well-renowned heart institutions in the United States and Internationally. We need your help to make sure that this valuable and highly specialized program is able to keep its tremendous repository of expertise by providing them with the necessary tools and facilities. The Advanced Heart Failure Program
Therapeutic Strategies in Advanced Heart Failure As a quaternary treatment facility, PMCC is one of the few major heart centers in North America that has the critical mass of expertise and resources necessary to truly impact the way heart failure is treated. It does so by furthering research into the detection, prevention, and treatment of heart failure, and treating heart failure through drug therapy, mechanical interventions and eventually transplantation. The PMCC does so with the best patient outcomes in Canada for heart transplants and the best outcomes for heart surgeries in North America. We continually need the resources to continue advancing the therapeutic options to saving and making better the lives of patients affected by heart failure. The Advanced Heart Failure Fund supports research and education. The fellowship program continues to expand with applicants from Canada and abroad. Fellowship positions include clinical, basic and translational research, doctoral and postdoctoral opportunities. Cutting edge therapies in heart failure include the planned purchase of brand new, state-of-the-art ultra-filtration devices for outpatient fluid removal in patients with advanced heart failure, mechanical cardiac assist devices and in some cases the first introduction of these devices into the Canadian healthcare system. As with the seed funding, this program relies 100% on private support to fund the purchase of these devices. These commercially available devices – including the next generation of Left Ventricular Assist Devices (LVAD) or mechanical hearts – can support a failing heart for months or years, with improved quality of life for the patient--until the heart’s function recovers or until a donor heart is available for transplantation. UHN is one of the major heart transplant centers in North America that has the means to treat heart failure in patients through the use of mechanical hearts and by performing heart transplants The basic science lab is currently investigating novel techniques of myocardial protection during cardiac transplantation and new therapeutic strategies to prevent transplant coronary artery disease. The lab receives peer-reviewed research funding from the Canadian Institutes for Health Research and the Heart and Stroke Foundation of Ontario, but the amount of research funding by these agencies is constantly challenged and thus, the program needs your support to continue their award-winning research.
More in this section:
|
|
|||
|
© Toronto General & Western Hospital Foundation. All Rights Reserved. |